U.S., April 9 -- An application to own the trademark for 'FRAXLANZA' has been filed on Sep. 10, 2024.
Owner(s):
Larimar Therapeutics, Inc.; Three Bala Plaza East, Suite 506, , Pennsylvania
Goods and/or Services:
For: pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatme...